Merck: Covid-19 Vaccines

1. How would you compare the innovation funnel for vaccine development to what we saw in
   a fast-paced innovation cycle like what we saw in IDEO and its design thinking approach?
2. How much can you compress the vaccine development timeline? What steps do you have to
   take to achieve this? What risks do you take on if you try this?
3. Consider Exhibit 11 and try to develop a qualitative feel for factors that drive the selection of
   cohort size for a randomized control trial (RCT) for a new Covid-19 vaccine. What would you
   look for? Would China be a good place to conduct an RCT? Spain? What part of the U.S.?

Sample Solution

The post Merck: Covid-19 Vaccines appeared first on homework handlers.